Blue Cross Blue Shield of Rhode IslandCommercial · Coverage · Physician · RI · Oncology, Rheumatology, Ophthalmology +3 moreHigh impact
Drugs moving from the specialty pharmacy benefit to the medical benefit 4/1/21
Act
by Apr 1, 2021
Effective date
Apr 1, 2021
Identified
Jun 19, 2026
Summary
Effective April 1, 2021, BCBSRI moved 15 specialty drugs from the specialty pharmacy benefit to the medical benefit, making them eligible for buy-and-bill with specific HCPCS codes. These drugs no longer need to be obtained from AllianceRx/Walgreens Specialty Pharmacy and can be billed directly by providers using the designated HCPCS codes.
Get alerts when payers change rules like this one
We check Blue Cross Blue Shield of Rhode Island and other payers every day and email you when a change matches your specialty and state.
01Billing team must update system to bill these 15 specialty drugs using the specific HCPCS codes provided (J3262, J0585, J0586, etc.) instead of routing through specialty pharmacy.
02Update encounter forms with new HCPCS codes for buy-and-bill procedures.
03Add administration codes as previously utilized.
04Verify prior authorization status through CoverMyMeds, fax, or mail for drugs requiring MDR program approval.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.